Results 151 to 160 of about 73,988 (260)

Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult‐to‐Control Hypertension: An Overview for Primary Care Physicians

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Hypertension remains one of the most prevalent and consequential modifiable cardiovascular risk factors worldwide, affecting approximately 1.28 billion adults globally and nearly half of the United States population. Despite the availability of effective therapies, optimal blood pressure control is achieved in fewer than one in four ...
Matthew A. Cavender
wiley   +1 more source

[Establishment and international comparison of reference methods for glycated hemoglobin]. [PDF]

Se Pu
Wang M, Zhang SL, Zhang R, Song YC, Shi J, Xue QZ, Hu YW.   +6 more
europepmc   +1 more source

Hepatic Safety of Orforglipron in Adults With Obesity or Overweight and/or Type 2 Diabetes: A Pooled Analysis of the Orforglipron Phase 3 Clinical Trials

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Orforglipron is a novel small‐molecule, once daily oral non‐peptide GLP‐1 receptor agonist. The hepatic safety profile in adults with obesity or overweight and/or type 2 diabetes (T2D) across seven orforglipron Phase 3 clinical trials was assessed.
Sean Wharton, Adam Stefanski, Jiaxun Chen, Girish Rao, Elvis Asare Twum, Max Denning   +5 more
wiley   +1 more source

Electrochemical Nanostructured Aptasensor for Direct Detection of Glycated Hemoglobin. [PDF]

Int J Mol Sci
Fritea L, Cotrut CM, Antoniac I, Cavalu SD, Dobjanschi L, Antonescu A, Moldovan L, Domuta M, Banica F.   +8 more
europepmc   +1 more source

Cardiovascular Efficacy of GLP‐1 Receptor Agonists by Kidney Function: An Updated Meta‐Analysis of Randomized Trials Including the SOUL Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the cardiovascular efficacy and absolute benefit of glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) by baseline estimated glomerular filtration rate (eGFR). Materials and Methods PubMed and EMBASE were searched to 29 April 2026 for randomized placebo‐controlled trials of GLP‐1RAs in adults with type 2 diabetes or ...
Masashi Hasebe, Chen‐Yang Su, Daisuke Yabe, Satoshi Yoshiji   +3 more
wiley   +1 more source

Relation of Serum α-Amylase Level With Glycated Hemoglobin and Trace Elements in Patients With Diabetes Mellitus. [PDF]

AACE Endocrinol Diabetes
Mahmud DA, Islam MM, Rahaman MM, Ripon MAR, Quarishi SB, Hossain MS.   +5 more
europepmc   +1 more source

Impact of iGlarLixi on Glycaemic Control Depth and Variability in Asian Pacific People With Type 2 Diabetes: A Post Hoc Analysis of LixiLan‐O‐AP and LixiLan‐L‐CN

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the impact of iGlarLixi on the depth of glycaemic control, glycaemic variability (GV) and postprandial glucose (PPG) control versus insulin glargine 100 U/mL (iGlar) or lixisenatide (Lixi) in Asian Pacific individuals with type 2 diabetes (T2D).
Jiaying Ni, Jingyi Lu, Fei Gao, Min Li, Minlu Zhang, Qin Du, Lei Kang, Danfeng Peng, Jian Zhou   +8 more
wiley   +1 more source

Evaluation of the relationship between glycated hemoglobin (HbA1c) levels and diabetes and other diseases: A retrospective study. [PDF]

Pak J Med Sci
Goktas O.
europepmc   +1 more source

Analysis of the Relationship Between Glycated Hemoglobin and Echocardiographic Parameters in Patients Without Diabetes: A Retrospective Study. [PDF]

J Clin Med
Jakubiak GK, Pawlas N, Starzak M, Blachut D, Chwalba A, Wojciechowska C, Cieślar G.   +6 more
europepmc   +1 more source

Characterising Continuous Glucose Monitoring Metrics Across Normoglycaemia, Prediabetes and Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Simon L. Cichosz, Kristine Færch, Morten H. Jensen   +2 more
wiley   +1 more source